ID   IMS-M1
AC   CVCL_A623
SY   IMS/M1; IMS/MI; IMS-MI
DR   Cosmic; 787437
DR   Cosmic; 975256
DR   Cosmic; 996321
DR   Cosmic; 1037672
DR   Cosmic; 1281319
DR   Cosmic; 2089654
DR   Cosmic; 2378128
DR   Wikidata; Q54897680
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8180386;
RX   PubMed=8414510;
RX   PubMed=14504097;
RX   PubMed=14671638;
RX   PubMed=23955599;
CC   Population: Japanese.
CC   Characteristics: CSF2 dependent.
CC   Doubling time: 36-48 hours (DOI=10.1016/B978-0-12-221970-2.50457-5).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (PubMed=14671638).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=8180386; DOI=10.1182/blood.V83.10.2912.2912;
RA   Yamamoto K., Seto M., Iida S., Komatsu H., Kamada N., Kojima S.,
RA   Kodera Y., Nakazawa S., Saito H., Takahashi T., Ueda R.;
RT   "A reverse transcriptase-polymerase chain reaction detects
RT   heterogeneous chimeric mRNAs in leukemias with 11q23 abnormalities.";
RL   Blood 83:2912-2921(1994).
//
RX   PubMed=8414510;
RA   Iida S., Seto M., Yamamoto K., Komatsu H., Tojo A., Asano S.,
RA   Kamada N., Ariyoshi Y., Takahashi T., Ueda R.;
RT   "MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a
RT   serine/proline rich protein homologous to MLLT1 on 19p13.";
RL   Oncogene 8:3085-3092(1993).
//
RX   PubMed=14504097; DOI=10.1182/blood-2003-02-0418;
RA   Taketani T., Taki T., Sugita K., Furuichi Y., Ishii E., Hanada R.,
RA   Tsuchida M., Sugita K., Ida K., Hayashi Y.;
RT   "FLT3 mutations in the activation loop of tyrosine kinase domain are
RT   frequently found in infant ALL with MLL rearrangements and pediatric
RT   ALL with hyperdiploidy.";
RL   Blood 103:1085-1088(2004).
//
RX   PubMed=14671638; DOI=10.1038/sj.leu.2403236;
RA   Drexler H.G., Quentmeier H., MacLeod R.A.F.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   MLL gene alterations.";
RL   Leukemia 18:227-232(2004).
//
RX   PubMed=23955599; DOI=10.1038/ng.2731;
RA   Kon A., Shih L.-Y., Minamino M., Sanada M., Shiraishi Y., Nagata Y.,
RA   Yoshida K.-i., Okuno Y., Bando M., Nakato R., Ishikawa S.,
RA   Sato-Otsubo A., Nagae G., Nishimoto A., Haferlach C., Nowak D.,
RA   Sato Y., Alpermann T., Nagasaki M., Shimamura T., Tanaka H., Chiba K.,
RA   Yamamoto R., Yamaguchi T., Otsu M., Obara N., Sakata-Yanagimoto M.,
RA   Nakamaki T., Ishiyama K., Nolte F., Hofmann W.-K., Miyawaki S.,
RA   Chiba S., Mori H., Nakauchi H., Koeffler H.P., Aburatani H.,
RA   Haferlach T., Shirahige K., Miyano S., Ogawa S.;
RT   "Recurrent mutations in multiple components of the cohesin complex in
RT   myeloid neoplasms.";
RL   Nat. Genet. 45:1232-1237(2013).
//